Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Sex, drugs and sports: prostaglandins, epitestosterone and sexual development.

Sanders BK.

Med Hypotheses. 2007;69(4):829-35. Epub 2007 Mar 23. Erratum in: Med Hypotheses. 2011 Jan;76(1):152.

PMID:
17382481
3.

Determination of 13C/12C ratios of urinary epitestosterone and its main metabolites 5alpha- and 5beta-androstane-3alpha, 17alpha-diol.

Piper T, Riemann P, Opfermann G, Mareck U, Geyer H, Vajiala G, Flenker U, Schänzer W.

Drug Test Anal. 2009 Nov;1(11-12):576-86. doi: 10.1002/dta.53.

PMID:
20355174
4.
5.

Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 alpha-hydroxyprogesterone.

Carlström K, Palonek E, Garle M, Oftebro H, Stanghelle J, Björkhem I.

Clin Chem. 1992 Sep;38(9):1779-84.

6.

Establishing a ketoconazole suppression test for verifying testosterone administration in the doping control of athletes.

Oftebro H, Jensen J, Mowinckel P, Norli HR.

J Clin Endocrinol Metab. 1994 Apr;78(4):973-7.

PMID:
8157729
7.

Indomethacin inhibits lordosis induced by ring A-reduced progestins: possible role of 3alpha-oxoreduction in progestin-facilitated lordosis.

Beyer C, González-Flores O, Ramírez-Orduña JM, González-Mariscal G.

Horm Behav. 1999 Feb;35(1):1-8.

PMID:
10049597
8.

Induction of PGE2 by estradiol mediates developmental masculinization of sex behavior.

Amateau SK, McCarthy MM.

Nat Neurosci. 2004 Jun;7(6):643-50. Epub 2004 May 23.

PMID:
15156148
9.

Epitestosterone: a potential new antiandrogen.

Nuck BA, Lucky AW.

J Invest Dermatol. 1987 Aug;89(2):209-11.

10.

Flowers for Algernon: steroid dysgenesis, epigenetics and brain disorders.

Sanders BK.

Pharmacol Rep. 2012;64(6):1285-90. Review.

11.

Epitestosterone.

Stárka L.

J Steroid Biochem Mol Biol. 2003 Oct;87(1):27-34. Review.

PMID:
14630088
12.
13.

Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: endogenous steroids urinary profile after multiple oral doses.

Mazzarino M, Braganò MC, de la Torre X, Molaioni F, Botrè F.

Steroids. 2011 Nov;76(12):1400-6. doi: 10.1016/j.steroids.2011.06.005. Epub 2011 Jun 30.

PMID:
21745489
14.

Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis.

van de Kerkhof DH, de Boer D, Thijssen JH, Maes RA.

J Anal Toxicol. 2000 Mar;24(2):102-15. Review.

PMID:
10732948
15.
16.

Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.

Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA.

Br J Pharmacol. 1997 May;121(1):125-33.

17.
18.

Quantitative confirmation of testosterone and epitestosterone in human urine by LC/Q-ToF mass spectrometry for doping control.

Danaceau JP, Scott Morrison M, Slawson MH.

J Mass Spectrom. 2008 Jul;43(7):993-1000. doi: 10.1002/jms.1443.

PMID:
18563866
19.

High doses of alcohol increase urinary testosterone-to-epitestosterone ratio in females.

Karila T, Kosunen V, Leinonen A, Tähtelä R, Seppälä T.

J Chromatogr B Biomed Appl. 1996 Dec 6;687(1):109-16.

PMID:
9001958
20.

Factors influencing the steroid profile in doping control analysis.

Mareck U, Geyer H, Opfermann G, Thevis M, Schänzer W.

J Mass Spectrom. 2008 Jul;43(7):877-91. doi: 10.1002/jms.1457. Review.

PMID:
18570179

Supplemental Content

Support Center